Semi-specific immuno-absorption and monoclonal antibody therapy in ANCA positive vasculitis: experience in four cases.
The treatment of renal limited systemic vasculitis usually involves a combination of cytotoxic drugs and steroids. As shown by randomised prospective controlled trial, plasmapheresis may be of additional benefit for the management of patients with renal involvement severe enough to require dialysis...
Κύριοι συγγραφείς: | Elliott, J, Lockwood, C, Hale, G, Waldmann, H |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
1998
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Monoclonal-antibody therapy in systemic vasculitis.
ανά: Mathieson, P, κ.ά.
Έκδοση: (1990) -
MONOCLONAL-ANTIBODY THERAPY IN SYSTEMIC VASCULITIS
ανά: Mathieson, P, κ.ά.
Έκδοση: (1990) -
HUMANIZED MONOCLONAL-ANTIBODY THERAPY FOR SYSTEMIC VASCULITIS
ανά: Lockwood, C, κ.ά.
Έκδοση: (1993) -
Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy.
ανά: Lockwood, C, κ.ά.
Έκδοση: (1993) -
MONOCLONAL-ANTIBODIES IN SYSTEMIC VASCULITIS - LONG-TERM BENEFIT FROM SHORT-TERM THERAPY
ανά: Isaacs, J, κ.ά.
Έκδοση: (1993)